Post-earnings recap
Reported
Tue, Mar 19, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Aurinia Pharmaceuticals reported a loss per share of $0.17, but the stock still rose by 2.39% following the earnings announcement. Investors may have reacted positively despite the loss due to other factors not disclosed in this report. The lack of revenue data and management commentary leaves some uncertainty about the company's current position and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.17 | N/A | — |
| Revenue | $— | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.